Epstein-Barr virus reactivation is not causative for post-COVID-19 … – BMC Infectious Diseases

WHO, Coronavirus disease (COVID-19). : Post COVID-19 condition, https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition (2021).

Zimmermann P, Pittet LF, Curtis N. The challenge of studying long COVID: an updated review. Pediatr Infect Dis J. 2022;41(5):4246. https://doi.org/10.1097/INF.0000000000003502.

Article PubMed PubMed Central Google Scholar

Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):13346. https://doi.org/10.1038/s41579-022-00846-2.

Article CAS PubMed PubMed Central Google Scholar

Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, Huggins CF, Kwong ASF, Silverwood RJ, Di Gessa G, Bowyer RCE, Northstone K, Hou B, Green MJ, Dodgeon B, Doores KJ, Duncan EL, Williams FMK, Open SC, Steptoe A, Porteous DJ, McEachan RRC, Tomlinson L, Goldacre B, Patalay P, Ploubidis GB, Katikireddi SV, Tilling K, Rentsch CT, Timpson NJ, Chaturvedi N, Steves CJ. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. https://doi.org/10.1038/s41467-022-30836-0.

Article CAS PubMed PubMed Central Google Scholar

Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM. Lifelines Corona Research, persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):45261. https://doi.org/10.1016/S0140-6736(22)01214-4.

Article CAS PubMed PubMed Central Google Scholar

Fernandez-de-Las-Penas C, Cancela-Cilleruelo I, Rodriguez-Jimenez J, Gomez-Mayordomo V, Pellicer-Valero OJ, Martin-Guerrero JD, Hernandez-Barrera V, Arendt-Nielsen L, Torres-Macho J. Associated-Onset symptoms and Post-COVID-19 symptoms in hospitalized COVID-19 survivors infected with Wuhan, Alpha or Delta SARS-CoV-2 variant. Pathogens. 2022;11(7). https://doi.org/10.3390/pathogens11070725.

Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):22634. https://doi.org/10.1016/S0140-6736(22)00941-2.

Article CAS PubMed PubMed Central Google Scholar

Nunhofer V, Hoeggerl AD, Weidner L, Zimmermann G, Badstuber N, Grabmer C, Jungbauer C, Lindlbauer N, Neureiter H, Held N, Ortner T, Flamm M, Osterbrink J, Rohde E, Laner-Plamberger S. Long-COVID Rates Vary throughout the SARS-CoV-2 pandemic. J Infect Dis Ther. 2023;11(01). https://doi.org/10.4172/2332-0877.1000520.

Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 Infection. Nat Med. 2022;28(7):14617. https://doi.org/10.1038/s41591-022-01840-0.

Article CAS PubMed PubMed Central Google Scholar

Malkova A, Kudryavtsev I, Starshinova A, Kudlay D, Zinchenko Y, Glushkova A, Yablonskiy P, Shoenfeld Y. Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form, Pathogens. 2021;10(11). https://doi.org/10.3390/pathogens10111408.

OMahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, Karamchandani U, Simms-Williams N, Cassambai S, Ardavani A, Wilkinson TJ, Hawthorne G, Curtis F, Kingsnorth AP, Almaqhawi A, Ward T, Ayoubkhani D, Banerjee A, Calvert M, Shafran R, Stephenson T, Sterne J, Ward H, Evans RA, Zaccardi F, Wright S, Khunti K. The prevalence and long-term health effects of long covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. https://doi.org/10.1016/j.eclinm.2022.101762.

Article PubMed Google Scholar

Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. https://doi.org/10.1371/journal.pmed.1003773.

Article CAS PubMed PubMed Central Google Scholar

Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, Basson MD, Bennett TD, Bergquist T, Boudreau EA, Bramante CT, Byrd JB, Callahan TJ, Chan LE, Chu H, Chute CG, Coleman BD, Davis HE, Gagnier J, Greene CS, Hillegass WB, Kavuluru R, Kimble WD, Koraishy FM, Kohler S, Liang C, Liu F, Liu H, Madhira V, Madlock-Brown CR, Matentzoglu N, Mazzotti DR, McMurry JA, McNair DS, Moffitt RA, Monteith TS, Parker AM, Perry MA, Pfaff E, Reese JT, Saltz J, Schuff RA, Solomonides AE, Solway J, Spratt H, Stein GS, Sule AA, Topaloglu U, Vavougios GD, Wang L, Haendel MA, Robinson PN. Characterizing Long COVID: Deep Phenotype of a Complex Condition, E Bio Medicine. 2021;74:103722. https://doi.org/10.1016/j.ebiom.2021.103722.

Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, Taverner T, Chandan JS, Brown K, Simms-Williams N, Shah AD, Singh M, Kidy F, Okoth K, Hotham R, Bashir N, Cockburn N, Lee SI, Turner GM, Gkoutos GV, Aiyegbusi OL, McMullan C, Denniston AK, Sapey E, Lord JM, Wraith DC, Leggett E, Iles C, Marshall T, Price MJ, Marwaha S, Davies EH, Jackson LJ, Matthews KL, Camaradou J, Calvert M, Haroon S. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):170614. https://doi.org/10.1038/s41591-022-01909-w.

Article CAS PubMed PubMed Central Google Scholar

Ramakrishnan RK, Kashour T, Hamid Q, Halwani R, Tleyjeh IM. Unraveling the mystery surrounding Post-acute Sequelae of COVID-19. Front Immunol. 2021;12:686029. https://doi.org/10.3389/fimmu.2021.686029.

Article CAS PubMed PubMed Central Google Scholar

Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194202. https://doi.org/10.1038/s41590-021-01104-y.

Article CAS PubMed PubMed Central Google Scholar

Mantovani A, Morrone MC, Patrono C, Santoro MG, Schiaffino S, Remuzzi G, Bussolati G. Covid-19 Commission of the Accademia Nazionale dei, long covid: where we stand and challenges ahead. Cell Death Differ. 2022;29(10):1891900. https://doi.org/10.1038/s41418-022-01052-6.

Article PubMed PubMed Central Google Scholar

Cohen JI. Epstein-Barr virus Infection. N Engl J Med. 2000;343(7). https://doi.org/10.1056/NEJM200008173430707. 481 92.

Naendrup JH, Garcia Borrega J, Eichenauer DA, Shimabukuro-Vornhagen A, Kochanek M, Boll B. Reactivation of EBV and CMV in severe COVID-19-Epiphenomena or trigger of hyperinflammation in need of treatment? A large Case Series of critically ill patients. J Intensive Care Med. 2022;37(9):11528. https://doi.org/10.1177/08850666211053990.

Article PubMed PubMed Central Google Scholar

Paolucci S, Cassaniti I, Novazzi F, Fiorina L, Piralla A, Comolli G, Bruno R, Maserati R, Gulminetti R, Novati S, Mojoli F, Baldanti F. San Matteo Pavia, EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis. 2021;104:3159. https://doi.org/10.1016/j.ijid.2020.12.051.

Article CAS PubMed Google Scholar

Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr Virus Reactivation. Pathogens. 2021;10(6). https://doi.org/10.3390/pathogens10060763.

Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME, Unit IS-SC-B, Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DSB, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881895e20. https://doi.org/10.1016/j.cell.2022.01.014.

Article CAS PubMed PubMed Central Google Scholar

Eisenhut M. Neopterin in Diagnosis and Monitoring of Infectious Diseases, J Biomark. 2013;2013:196432. https://doi.org/10.1155/2013/196432.

Weidner L, Nunhofer V, Jungbauer C, Hoeggerl AD, Gruner L, Grabmer C, Zimmermann G, Rohde E, Laner-Plamberger S. Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors. Infection. 2021;49(6):118794. https://doi.org/10.1007/s15010-021-01639-0.

Article CAS PubMed PubMed Central Google Scholar

Nunhofer V, Weidner L, Hoeggerl AD, Zimmermann G, Badstuber N, Grabmer C, Jungbauer C, Lindlbauer N, Held N, Pascariuc M, Ortner T, Rohde E. Laner-Plamberger, persistence of naturally acquired and functional SARS-CoV-2 antibodies in blood donors one year after Infection. Viruses. 2022;14(3). https://doi.org/10.3390/v14030637.

Hess RD. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol. 2004;42(8):33817. https://doi.org/10.1128/JCM.42.8.3381-3387.2004.

Article PubMed PubMed Central Google Scholar

De Paschale M, Clerici P. Serological diagnosis of Epstein-Barr virus Infection: problems and solutions. World J Virol. 2012;1(1):3143. https://doi.org/10.5501/wjv.v1.i1.31.

Article PubMed PubMed Central Google Scholar

AbuSalah MAH, Gan SH, Al-Hatamleh MAI, Irekeola AA, Shueb RH. Yean Yean, recent advances in Diagnostic approaches for Epstein-Barr Virus. Pathogens. 2020;9(3). https://doi.org/10.3390/pathogens9030226.

Bu W, Hayes GM, Liu H, Gemmell L, Schmeling DO, Radecki P, Aguilar F, Burbelo PD, Woo J, Balfour HH Jr., Cohen JI. Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after primary Infection with EBV. Clin Vaccine Immunol. 2016;23(4):3639. https://doi.org/10.1128/CVI.00674-15.

Article CAS PubMed PubMed Central Google Scholar

Noguchi K, Gel YR, Brunner E, Konietschke F. nparLD: an R Software Package for the Nonparametric Analysis of Longitudinal Data in Factorial experiments. J Stat Softw. 2012;50(12):123.

Article Google Scholar

R-Core-Team. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria., in: R-Core-Team, editor R-Core-Team, 2022.

Mayersbach P, Fuchs D, Schennach H. Performance of a fully automated quantitative neopterin measurement assay in a routine voluntary blood donation setting. Clin Chem Lab Med. 2010;48(3):3737. https://doi.org/10.1515/CCLM.2010.072.

Article CAS PubMed Google Scholar

Robertson J, Gostner JM, Nilsson S, Andersson LM, Fuchs D, Gisslen M. Serum neopterin levels in relation to mild and severe COVID-19. BMC Infect Dis. 2020;20(1):942. https://doi.org/10.1186/s12879-020-05671-7.

Article CAS PubMed PubMed Central Google Scholar

Bellmann-Weiler R, Lanser L, Burkert F, Seiwald S, Fritsche G, Wildner S, Schroll A, Koppelstatter S, Kurz K, Griesmacher A, Weiss G. Neopterin predicts Disease Severity in hospitalized patients with COVID-19. Open Forum Infect Dis. 2021;8(1):ofaa521. https://doi.org/10.1093/ofid/ofaa521.

Article CAS PubMed Google Scholar

Nagata K, Hayashi K. Epstein-Barr Virus Reactivation-Induced Immunoglobulin production: significance on autoimmunity. Microorganisms. 2020;8(12). https://doi.org/10.3390/microorganisms8121875.

Nunn AVW, Guy GW, Brysch W, Botchway SW, Frasch W, Calabrese EJ, Bell JD. SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing. Immun Ageing. 2020;17(1):33. https://doi.org/10.1186/s12979-020-00204-x.

Article CAS PubMed PubMed Central Google Scholar

Yang Y, Yang M, Peng Y, Liang Y, Wei J, Xing L, Guo L, Li X, Li J, Wang J, Li M, Xu Z, Zhang M, Wang F, Shi Y, Yuan J, Liu Y. Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after Infection. Nat Microbiol. 2022;7(3):42333. https://doi.org/10.1038/s41564-021-01051-2.

Article CAS PubMed Google Scholar

Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, Chan F, Lu S, Goldberg SA, Hoh R, Tai V, Torres L, Iyer NS, Deswal M, Ngo LH, Buitrago M, Rodriguez A, Chen JY, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Deitchman AN, Hellmuth J, Spinelli MA, Durstenfeld MS, Hsue PY, Kelly JD, Martin JN, Deeks SG, Hunt PW, Henrich TJ. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023;133(3). https://doi.org/10.1172/JCI163669.

Maurmann S, Fricke L, Wagner HJ, Schlenke P, Hennig H, Steinhoff J, Jabs WJ. Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers. J Clin Microbiol. 2003;41(12):541928. https://doi.org/10.1128/JCM.41.12.5419-5428.2003.

Article CAS PubMed PubMed Central Google Scholar

Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Reem Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. https://doi.org/10.1016/j.eclinm.2021.101019.

Article PubMed PubMed Central Google Scholar

Ziauddeen N, Gurdasani D, OHara ME, Hastie C, Roderick P, Yao G, Alwan NA. Characteristics and impact of Long Covid: findings from an online survey. PLoS ONE. 2022;17(3):e0264331. https://doi.org/10.1371/journal.pone.0264331.

Article CAS PubMed PubMed Central Google Scholar

More here:

Epstein-Barr virus reactivation is not causative for post-COVID-19 ... - BMC Infectious Diseases

Related Posts
Tags: